Anti-bacterial monoclonal antibodies: Back to the future?
Authors:
- Gábor NagyGNGábor Nagy
- Eszter NagyENEszter Nagy
- 1 October 2012
- journal article
- review article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 526 (2) , 124-131
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Will new antimicrobials overcome resistance among Gram-negatives?Expert Review of Anti-infective Therapy, 2011
- Multiresistant Gram-negative infections: a global perspectiveCurrent Opinion in Infectious Diseases, 2010
- Healthcare-associated versus community-acquired infections: A new challenge for science and societyInternational Journal of Medical Microbiology, 2010
- Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococciClinical Microbiology and Infection, 2009
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPEThe Journal of Infectious Diseases, 2008
- Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosaClinical Infectious Diseases, 2006
- Panresistance in VIM-1-producing Klebsiella pneumoniaeJournal of Antimicrobial Chemotherapy, 2005
- Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?Clinical Infectious Diseases, 2002
- Serum therapy revisited: animal models of infection and development of passive antibody therapyAntimicrobial Agents and Chemotherapy, 1994
- Staphylococcal Infection: Antitoxic ImmunityBMJ, 1960